Toxicology and safety of DHA.

scientific article published on 06 June 2009

Toxicology and safety of DHA. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.PLEFA.2009.05.004
P8608Fatcat IDrelease_ihlopywiczebfi7xlfyus5htra
P698PubMed publication ID19501496

P2093author name stringEric L Lien
P433issue2-3
P304page(s)125-132
P577publication date2009-06-06
P1433published inProstaglandins, Leukotrienes and Essential Fatty AcidsQ15753414
P1476titleToxicology and safety of DHA.
P478volume81

Reverse relations

cites work (P2860)
Q64099870Association between Breastmilk LC PUFA, Carotenoids and Psychomotor Development of Exclusively Breastfed Infants
Q28392829Chemoprotective epigenetic mechanisms in a colorectal cancer model: Modulation by n-3 PUFA in combination with fermentable fiber
Q33765435Chronic oral or intraarticular administration of docosahexaenoic acid reduces nociception and knee edema and improves functional outcomes in a mouse model of Complete Freund's Adjuvant-induced knee arthritis
Q34330929Current evidence for the clinical use of long-chain polyunsaturated n-3 fatty acids to prevent age-related cognitive decline and Alzheimer's disease.
Q36759050Daily Enteral DHA Supplementation Alleviates Deficiency in Premature Infants
Q30985506Dietary Docosahexaenoic Acid Improves Cognitive Function, Tissue Sparing, and Magnetic Resonance Imaging Indices of Edema and White Matter Injury in the Immature Rat after Traumatic Brain Injury
Q33799635Dietary long-chain omega-3 fatty acids do not diminish eosinophilic pulmonary inflammation in mice.
Q42694887Docosahexaenoic acid is a beneficial replacement treatment for spinocerebellar ataxia 38.
Q39591498Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms
Q34540353Docosahexaenoic acid supplementation does not improve Western diet-induced cardiomyopathy in rats
Q52726199Effects of the polyunsaturated fatty acids, EPA and DHA, on hematological malignancies: a systematic review.
Q39200406Emerging role of chemoprotective agents in the dynamic shaping of plasma membrane organization
Q51746396Enteral Arg-Gln Dipeptide Administration Increases Retinal Docosahexaenoic Acid and Neuroprotectin D1 in a Murine Model of Retinopathy of Prematurity.
Q42879612Estimated macronutrient and fatty acid intakes from an East African Paleolithic diet
Q26999257Fishy business: effect of omega-3 fatty acids on zinc transporters and free zinc availability in human neuronal cells
Q57175927Long-Chain n-3 Fatty Acids Attenuate Oncogenic KRas-Driven Proliferation by Altering Plasma Membrane Nanoscale Proteolipid Composition
Q35059491Maternal omega-3 fatty acid supplementation and risk for perinatal maternal depression
Q34494043Mechanisms by Which Pleiotropic Amphiphilic n-3 PUFA Reduce Colon Cancer Risk
Q38700383Natural Docosahexaenoic Acid in the Triglyceride Form Attenuates In Vitro Microglial Activation and Ameliorates Autoimmune Encephalomyelitis in Mice.
Q52329039Omega-3 fatty acids, membrane remodeling and cancer prevention.
Q36049510Partial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oil
Q64884810Pharmacokinetics and Oxidation Parameters in Volunteers Supplemented with Microencapsulated Docosahexaenoic Acid.
Q24202453Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders
Q24234130Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders
Q38966524Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders.
Q45932582Preclinical assessment of infant formula.
Q64069790Reduction of elevated lipids and low-density lipoprotein oxidation in serum of individuals with subclinical hypoxia and oxidative stress supplemented with lycosome formulation of docosahexaenoic acid
Q48040778Role of Omega-3 PUFAs in Neurobiological Health
Q38229311Supplemental substances derived from foods as adjunctive therapeutic agents for treatment of neurodegenerative diseases and disorders

Search more.